‘Women and their doctors should become aware of this proof when deciding how long to keep tamoxifen, or any additional endocrine treatment,’ stated Davies in a news release. The ATLAS study results were simultaneously published in The Lancet. Related StoriesSausages With Antioxidants From Berries To Prevent CancerStudy shows rare HER2 missense mutations do not spread breasts cancer on the ownMD Anderson research reveals why chemotherapy medications not effective for most pancreatic cancers patientsThe ATLAS trial included 6846 women with ER-positive breast malignancy, half of whom got node-positive disease.As our U.S. Healthcare operations continue steadily to expand, providing cutting-edge health care to those in need, all of us at AHF look forward to dealing with Dr. Khanlou in this new leadership role.WORK showcases potential innovations and technology in deep learning softwareDr. Khanlou has practiced in a wide variety of medical communities in the U.S. And overseas like the Albert Einstein Medical Center in Philadelphia, Pennsylvania, Queen of Angels-Hollywood Presbyterian INFIRMARY, California INFIRMARY, Cedars-Sinai INFIRMARY, University of Los Angeles Medical Center, Cochin Hospital in Paris, France and Joffre Hospital in Draveil, France. He completed his undergraduate work and received his medical level from the Bobigny Medical College at the University of Paris XIII.